Switzerland · Investor

Aeris Capital

Last cheque observed May 2015. Silence since then is not evidence of inactivity: our sources miss unannounced rounds.

QuietGrowth equityWebsite unconfirmed

Series CSeries DSeries AE-CommerceInternet

Cheques on record
0%of best year0cheques in 12 months, 33 on record
Since the last cheque4176days00hrs00min00sec
Median round$18MRounds led0 of 33Sole investor4 roundsExits3 from the portfolioMostly inUnited States, 79%
Pitch Aeris Capital

Aeris Capital highlights

  1. 01

    33 rounds on record

  2. 02

    Mostly Series C and Series D: 48% of its rounds

  3. 03

    Sole investor in 4 rounds, median $6.0M

  4. 04

    3 exits from the portfolio

What they do

Type
Growth equity (from a list, unverified)
Cheque size
Not stated
Sectors
E-CommerceInternet
Based in
Zurich, Switzerland
Cold pitches
Not stated

A website was listed for this organisation, but we could not confirm it belongs to the firm that wrote these cheques. Either the site never mentions them, or it turned out to be a different company sharing the name. We show neither it nor anything read from it. Tell us the right one.

The record

Every round we can evidence, newest first33 appearances

  1. 2015

    1 round

  2. May
    JiffSeries C · US$23MWith 4 others
  3. 2014

    5 rounds

  4. Nov
    CuretisSeries B · DE$18MWith 6 others
  5. Nov
    Butterfly NetworkGrowth · US · Firms' own news pages$100MWith 1 other
  6. Sept
    JiffSeries B · US$18MWith 2 others
  7. Sept
    Affimed TherapeuticsSeries E · DE$16MWith 2 others
  8. Aug
    SmaatoSeries E · US$25MWith 2 others
  9. 2013

    4 rounds

  10. Dec
    InvinceaSeries C · US$16MWith 4 others
  11. Sept
    GenomeDx BiosciencesSeries B · CA · socaltech.comUndisclosedWith 3 others
  12. Jan
    Solstice BiologicsSeries A · US · finsmes.com$18MWith 1 other
  13. Jan
    Crescendo BioscienceSeries D · US · pevc.dowjones.com$28MWith 4 others
  14. 2012

    5 rounds

  15. Dec
    Solstice BiologicsGrowth · US · sec.gov$7.5MWith 1 other
  16. Jun
    NanosolarGrowth · US · forbes.com$70MWith 2 others
  17. Mar
    JiffSeries A · US · freshnews.com$7.5MWith 2 others
  18. Jan
    GenomeDx BiosciencesSeries A · CA · finsmes.comUndisclosedWith 1 other
  19. Jan
    LivescribeVenture · US$3.3MWith 6 others
  20. 2011

    6 rounds

  21. Sept
    Crescendo BioscienceSeries C · US · crescendobio.com$56MWith 2 others
  22. Jul
    SynapSenseSeries C · US · techcrunch.com$16MWith 6 others
  23. Jun
    SmaatoSeries C · US$3.0MWith 1 other
  24. Jun
    SmaatoSeries D · US$3.0MWith 1 other
  25. Jan
    SmaatoSeries C · US · smaato.com$7.0MWith 1 other
  26. Jan
    Coda AutomotiveSeries D · US · techcrunch.com$76MWith 3 others
  27. 2010

    4 rounds

  28. Sept
    LivescribeSeries C · US · livescribe.com$39MWith 8 others
  29. May
    Coda AutomotiveSeries C · US · prnewswire.com$58MWith 3 others
  30. Apr
    Affimed TherapeuticsSeries C · DE · fiercebiotech.com$27MWith 2 others
  31. Feb
    Mode MediaSeries E · US · techcrunch.com$50MWith 1 other
  32. 2009

    6 rounds

  33. Dec
    CuretisSeries A · DE · curetis.com$28MWith 3 others
  34. Dec
    SmaatoSeries B · US · digital.venturebeat.com$4.5MSole investor
  35. Nov
    Tethys BioScienceSeries D · US · deals.venturebeat.com$25MWith 4 others
  36. Oct
    Adamas PharmaceuticalsSeries D · US · onbiovc.com$40MWith 3 others
  37. Aug
    ConforMISSeries D · US · onbiovc.com$50MSole investor
  38. Mar
    LivescribeSeries B · US · dealipedia.com$7.5MSole investor
  39. 2008

    2 rounds

  40. Mar
    mobileoSeed · DE$3.8MSole investor
  41. Jan
    SmaatoSeries A · US · venturebeat.com$3.6MWith 1 other

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

The team

We hold 4 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.

Exits from the portfolio

Companies it backed that were later bought or listed3 in all

LivescribeBought by Anoto Group$15MNov 2015
SynapSenseBought by PanduitUndisclosedMay 2014
Crescendo BioscienceBought by Myriad Genetics$270MFeb 2014

An exit counts when it came after the firm's first round in the company. From historical deal records.

Who they invest alongside

The investors most often in the same rounds as Aeris Capital. A count of rooms they were both in, not a relationship either has claimed.

Mohr Davidow VenturesVC firm5rounds togetherAberdare VenturesVC firm3rounds togetherEDBIVC firm3rounds togetherEQT life sciencePrivate equity3rounds togetherKleiner Perkins Caufield & ByersVC firm3rounds togetherBaird CapitalWealth manager2rounds togetherBioMedInvestGrowth equity2rounds togetherBioMedPartnersPrivate equity2rounds togetherCD-VentureVC firm2rounds togetherCrosslink CapitalVC firm2rounds togetherEDB InvestmentsGrowth equity2rounds togetherKeating CapitalGrowth equity2rounds together

Quick answers about Aeris Capital

What does Aeris Capital invest in?

Aeris Capital invests most often at Series C and Series D (48% of the rounds on record), in sectors such as E-Commerce and Internet.

How active is Aeris Capital?

33 investments on record, 0 of them in the last 12 months. The most recent was in May 2015.

How big are Aeris Capital's cheques?

The median round it joins is $18M.

Does Aeris Capital lead rounds?

Rarely, if at all: none of its 33 investments on record names it as the lead.

Where does Aeris Capital invest?

Most of the companies it backs are in the United States (79%), Germany (15%) and Canada (6%).

Is Aeris Capital investing now?

No investments in the last 12 months; the latest was in May 2015.

Who does Aeris Capital invest alongside?

Most often Mohr Davidow Ventures (5 rounds together), Aberdare Ventures (3 rounds together) and EDBI (3 rounds together).

What kind of investor is Aeris Capital?

Aeris Capital is a growth equity firm based in Zurich, Switzerland.

Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Find similar investorsOpen your CRM

Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it